Sample assessment
The source identifies a pharmaceutical powder without naming its active ingredient or formulation. The setup lists a PTFE jar and zirconia media.
Analyst consideration: A pharmaceutical mesh result should be considered with the formulation and any heat- or contact-sensitive quality attributes. The short duration is useful evidence, but does not substitute for checking those attributes.
Recorded objective
Meet the recorded 100-mesh requirement.
Equipment and selection
The machine entry is XQM. TENCAN Vertical square planetary ball mill is associated at the recorded series level. No exact housing variant is inferred from jar capacity or an abbreviated machine label.
Test setup
| Jar entry | PTFE500 |
|---|---|
| Media entry | Zirconia 500 |
| Media-charge notation | Standard charge; individual specification not recorded |
| Sample-load entry | 32 (unit not stated) |
| Controller speed setting | 400 |
| Cycle notation | 5/1 |
Unlabelled jar, media and load numbers remain source notation, not assigned units. Controller settings are not certified rpm. The cycle notation has no independently stated timing unit or reversing definition.
Recorded procedure and results
The procedure states that two minutes was sufficient, and the result field is explicitly marked accepted. The recorded controller setting is 400. No sieve-passing percentage, particle-size distribution, sample-temperature measurement or pharmaceutical quality assay was included.
Interpretation
The result supports reported acceptance of this particular short test. The source does not prove that every particle passed a specified aperture or that the milled material retained its pharmaceutical characteristics.
Practical precautions
Confirm the formulation and the acceptance sieve standard before repeating. Weigh and recover the charge and use a relevant quality test in addition to the recorded fineness check.
TENCAN alternatives to evaluate
TENCAN Planetary ball mill (semi-circular model). A compatible benchtop setup can be considered for the short pharmaceutical test. Match the PTFE-contact arrangement and confirm that the same 100-mesh acceptance method applies. A benchtop configuration can be compared for compatible jar loading and handling of the short test; no automatic pharmaceutical quality or finer-size benefit follows from the housing choice. This is an untested comparison proposal, not a result of this trial.
Association follows the explicit XQM source entry; only recorded tested series/configurations are related. No jar-volume inference.
About this trial
TENCAN laboratory trial, 2017–2020. Observations above come from this experimental record; selection considerations and proposed comparisons are engineering interpretation. Results apply to this sample and recorded conditions.